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CASE REPORT
INTRODUCTION
Chronic diarrhea or signs of malabsorption are
commonly encountered by general internists and
gastroenterologists. A malabsorption syndrome may be
associated with several diseases including infection and
systemic diseases. Systemic amyloidosis, however, is
often overlooked in the differential diagnosis of
malabsorption.1 Amyloidosis is a series of diseases in
which there is extracellular deposition of a protein which
folds into an insoluble â pleated sheet.2-9 Primary
amyloidosis is a monoclonal plasma cell disorder with
an incidence of approximately 8 per million per year,
its subtypes are classified according to the
composition of the amyloid subunit protein.1,3-5 This
disease has a male preponderance of 60% to 65% and
affects 99% patients older than 40 years of age.3
Secondary systemic amyloidosis is a disorder in which
insoluble protein fibers become deposited in tissues and
organs impairing their function. It is found in
association with chronic infection or chronic
inflammatory disease.4,5,6,7
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ABSTRACT
Amyloidosis is a rare disease, when diagnosed it’s incurable and mostly affect over 40 years old male.
Diagnostic is confirmed if histopathologic stained positive with Congo red and evidence of monoclonal
protein. Survivals for untreated patients are 13 months in  primary amyloidosis but if secondary to other
chronic disease and systemic, survival could be 3-4 years. It can not be prevented but when affected,
control of the underlying illness can prevent progression of amyloidosis.
We report a rare case of a 67 year old male, who came with chronic diarrhea. The stool analysis, there
were no negative gram microorganisme found, only food maldigestion and fungus infection. Stool
analyze from parasitology department were found microspore, but the stool culture were sterile.
The patient underwent colonoscopy which revealed hyperemis mucosa in rectum, sigmoid, descending &
transverse colon. From the biopsy was concluded intestinal amyloidosis. We treated the patient
symptomatically and couldn’t find the underlying inflammatory disease which causes the problem.
Keywords: secondary amyloidosis, chronic diarrhea, malabsorption, colonoscopy, protein
electrophoresis
Fatigue and weight loss are the most common
presenting symptoms. Light headedness due to
autonomic neuropathy and or orthostatic hypotension
is also common. Other symptoms like easy bruising,
rapid onset of breathlessness, peripheral oedema,
sensory change (including carpal tunnel syndrome) or
postural hypotension should arouse suspicion of the
disease.2-5 Change in bowel habits like constipation,
chronic diarrhea, steatorrhea, abdominal pain,
distension, peritonitis, spontaneous gut perforation,
anorexia even obstruction may occur in
gastrointestinal amyloidosis. This could be due to
direct mucosal infiltration, intestinal ischemia or from
dysmotility caused by autonomic failure.1-5
From the physical examination there may be found
purpura above the nipple line, webbing of neck, face
and eyelids, macroglossia, submandibular
lymphadenopathy, hepatomegaly, muscle atrophy,
edema and signs of congestive heart failure if the heart
is involved.1-3
The Indonesian Journal of Gastroenterology, Hepatology, and Digestive Endoscopy92
Lydia D Simatupang, Kharia Utia, Ari Fahrial Syam,Marcellus Simadibrata, Arya Govinda, Ening Krisnuhoni
Laboratory findings may reveal anemia, elevated
sedimentation rate, proteinuria (could be in nephrotic
range) with or without renal dysfunction,
hypoalbuminemia, prolonged prothrombin time or other
acquired coagulation abnormalities, pseudoinfartion on
the electrocardiogram, restrictive hemodynamics on
the echocardiogram. The most important measure to
distinguish primary to secondary amyloidosis is protein
electrophoresis with immunofixation which can be
withdrawn from the serum or urine. Bone marrow
aspiration and biopsy or fat aspiration could be
performed if needed.1-5 When negative, findings for
underlying illness related to it should be investigated.
Colonoscopy commonly reveals mucosal friability and
erosions.3,4,8 Hystologic evidence stained with Congo
red (sensitivity of 90%) will demonstrate an apple-green
birefringence under polarizing light.1,3-9 This confirms
the diagnosis but not the subtype.2
Prognosis depends on the specific type of
amyloidosis and the organs involved.2,3-5 The cause of
death in most patients is cardiac and kidney related
disease.3,4 Hayman et al reported weight loss and low
hemoglobin concentration as worse prognostic
indicator on gastrointestinal amyloidosis.1
Management should remain supportive, diarrhea
may be managed with agents as loperamide and
ocreotide.1,9 Treatment with alkylating agent-based
chemotherapy, such as melphalan and prednisone may
extend the median survival rate from 1 year to
90 months in primary amyloidosis.2,3 But for
secondary amyloidosis, aggressive control of
the underlying cause can prevent progression of
amyloidosis.4,7,9
CASE REPORT
A 67 years old male, admitted to our hospital with
complaint of diarrhea since 2 weeks before admission.
He defecated 10 times a day, liquid stool, with
yellowish color of stool, no blood, but sometimes
contained mucus, his abdomen were bloated and
cramped, too. He feltfeverish, and after self
medication his diarrhea continued, aggravated with
decrease of appetite, decreased body weight he felt so
weak and the family took him to the hospital.
The patient was a smoker for 37 years, but quit
smoking since he knew he had coronary arterial
disease. He had hypertension since 13 years ago, but
after he was told he had coronary disease since 8 years
ago, he controlled regularly to the cardiology
outpatient department. Three years ago he had
abdominal pain and dyspepsia and made him to
undergo esofagogastroduodenoscopy and were told
he had erosive gastritis, which changed his medication
from aspilet to ascardia and had omeprazole added.
About 2 years ago, he underwent coronary angio by
pass graft (CABG). After his cardiac condition were
improved, he got additional drug since then, simvastatin,
which was stopped 1 month ago. He had history of
stroke too, about 1 year ago. His physical examination
on admission revealed no special remarks. He was fully
alert, but had body mass index of 14,7 his blood
pressure were 100/60 mmHg and other vital sign and
physical examination were normal, included no webbed
neck, macroglossia, lymphadenopathy, organomegaly
nor purpura or other skin abnormalities.
The patients were given antidiarrheal agents,
intravenous fluid besides enteral nutrition and
non-specific antibiotic on admission. On the second day
of admission he had melena, which stopped on
the 8th day of hospitalization, but after that he still
complaint of diarrhea. The patient underwent esofago
gastroduodenoscopy and the result was grade C
esophagitis, erosive pangastritis with atrophic
gastropathy, which explained the cause of melena.
The result of biopsy taken from esophagus was in
concordance of Barrett’s esophagus. He was given
proton pump inhibitor and sucralfat, and we planned to
evaluate this problem after 6 months of therapy. His
ECG revealed poor R on V1-V3, inverted T on lead
V4-V6, I, aVL. His Echocardiography revealed
consentric left ventricular hypertrophy, with good
systolic function, 61% ejection fraction and mild
diastolic dysfunction.
From his stool analysis, there were no negative gram
microorganism found, only food maldigestion and
fungus infection. Stool analyze from parasitology
department were found microspore, but the stool
culture were sterile. Antifungal were given and
antibiotics were stop. The patient underwent
colonoscopy which revealed hyperemis mucosa in
rectum, sigmoid, descending and transverse colon. With
differential diagnosis of infective colitis, ulcerative
colitis.
From the biopsy of the ileum, ascending colon and
rectosigmoid were found the same microscopic
abnormalities which concluded: intestinal amyloidosis.
No signs of malignancy. Protein electrophoresis was
taken after that and the results were normal.
DISCUSSION
This 67 years old male patient, came with chronic
diarrhea, which according to the stool analysis was due
to food maldigestion and opportunistic infection caused
by fungi. Colonoscopy revealed infective colitis with
differential diagnosis of ulcerative colitis, with
hystologic result of amyloidosis. This can explain
the chronic diarrhea due to malabsorption. Mechanism
of malabsorption in patients with intestinal amyloidosis
according to the literature, include autonomic
neuropathy, myopathy and dysmotility that lead to
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bacterial and or fungal overgrowth, vascular invasion,
mucosal injury and ischemia.9 Hayman et al stated that
malabsorption occurs in less than 5% of patients with
systemic amyloidosis with symptoms of diarrhea,
steatorrhea, anorexia, dizziness, orthostatis, nausea or
abdominal pain.1
The patient’s age and sex were in accordance with
primary amyloidosis, which is of male preponderance
(60% to 65%) and affects 99% patients older than
40 years of age. The histologic result revealed
amyloidosis, but the protein electrophoresis could not
show any abnormal monoclonal immunoglobulin light
chains, so amyloidosis in this patient is likely to be
secondary cause and primary amyloidosis can be
excluded. Besides, there were no symptoms and signs
of above the nipple line purpura, webbed neck,
macroglossia, submandibular lymphadenopathy,
hepatomegaly, muscle atrophy nor edema. There were
no signs of congestive heart failure, even the patient
has coronary arterial disease and has history of
coronary angio by pass graft. Anemia with
hemoglobin of 10.2 g/dl and loss of body weight
according to the literature are bad prognostic factor
for gastrointestinal amyloidosis.1
Amyloidosis were based on histological result, not
made with Congo Red stain, because there were no
facility of  polarization microscope with birefringence
lens at that time which was needed to read the result
and is the golden standard. Yet the histological pattern
appeared no doubt of amyloidosis (see figure 1).
In both primary and secondary amyloidosis, the most
commonly involved organ system is the gastro-
intestinal system, with the colon being the most
frequently involved organ.8 This suits the case, where
the colonoscopy was found colitis. Other part of
the gastrointestinal system which also can be affected
is the esophagus, where the muscular and Auerbach
plexus can be infiltrated with amyloid. The lower
esophageal sphincter’s tone will decrease, peristalsis
impaired and cause gastroesophageal reflux.1,8,10
This patient has abdominal pain and dyspepsia and
underwent esofagogastroduodenoscopy with result of
grade C esophagitis, erosive pangastritis with atrophic
gastropathy. The histopathologic result showed
Barrett’s esophagus, which in this case were
associated with chronic gastroesophageal reflux
possibly due to involvement of amyloidosis in
the esophagus, too. Other part of the gastrointestinal
system such as gastric involvement usually manifest
as gastric outlet obstruction, ulceration and bleeding
with endoscopic abnormalities revealing loss of rugae
or nodularity, which in this case only the bleeding
happened and there were no nodularity or rugae loss
so involvement of gastric amyloidosis is not proven.
Melena in this case was due to erosive pangastritis
in associated with anatomic mucosal defects, due to
prolonged use of NSAID and probably stressed ulcer,
but still amyloidosis can aggravate this condition.
Gastrointestinal bleeding related to amyloid is difficult
to control, because of blood vessel fragility and
mucosal stiffness, and if compounded by underlying
coagulation abnormalities (such as thrombocytopenia,
increased fibrinolytic activity, factor X deficiency, etc)
it would be more massive.10 In this case the platelet
count was still normal, and the bleeding time, clotting
time and prothrombine time were also normal and
the bleeding were not massive but took six days
before completely stopped.
Amyloidosis in this patient is supposed to be
secondary, but until discharged from the hospital there
Figure 1. Histologic appearance showed
chronic inflammation cells with amorf
eosinophilic mass in lamina propria, with
capillers circulating the eosinophillic mass
(see arrow)
Figure 2. Colonoscopy showed hyperemis
mucosa in rectum, sigmoid, descending and
transverse colon
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were no indication of inflammatory disease as primary
cause. He has no multiple myeloma, rheumatoid
arthritis, tuberculosis, systemic lupus erythomatosus,
hairy cellleukemia, cystic fibrosis, ankylosing spondilitis,
or other autoimmune or inflammatory disorder. Zhouli
et al report one case with primary cause of hepatitis B,
we couldn’t check for serolomarker of hepatitis B in
this case because of financial limitation.12
Secondary amyloidosis if happened can not be
prevented and there is no specific treatment for
the amyloid. The pathogenesis of amyloidosis is
unknown and therefore no specific management is
available at present. The treatment of amyloidosis aims
at reducing the stimuli from chronic inflammation,
inhibiting the production and deposition of amyloid
protein and promoting the lysis of amyloid protein. Some
chemotherapeutic drugs such as melphalan, prednisone
and colchilcine are effective in primary amyloidosis.
In secondary amyloidosis the treatment is towards
management of underlying condition to prevent
progression of amyloidosis.Aim of treatment is to
control the underlying disease and the symptoms, which
in this case is diarrhea and melena. We used
antifungal (sporadic) as well as antibiotics (cefotaxime)
to control the bacterial overgrowth and fungal
infection We gave antidiarrheal agent (loperamide) and
active charcoal with intravenous fluid to maintain
balanced fluid. Although no randomized data are
available, acid suppression therapy with proton pump
inhibitors is reasonable, eventhough one series report
that proton pump inhibitor does not prevent bleeding
recurrence.1,11 Sucralfate is to protect the gastric
mucosa and domperidone is given due to dysmotility.
Other supportive care was to give adequate nutrition
and calories. Unfortunately the underlying disease in
this case remains obscured.
CONCLUSION
The clinical manifestations of amyloidosis that
caused by amyloid deposition could be various, which
can make misleading diagnosis for many years after
the onset of symptom. Primary or secondary
amyloidosis should always be considered in
malabsorptive chronic diarrhea, especially in over
40 years old male patients.
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